Pune, India, Aug. 28, 2023 (GLOBE NEWSWIRE) — The global cardiovascular devices market size was USD 54.08 billion in 2021 and it is predicted to reach USD 86.27 billion by 2028, exhibiting a CAGR of 6.9% during the forecast period. The technological advancements in cardiovascular devices, such as the development of artificial intelligence (AI)-powered devices, are […]
Category Archives: Cardiovascular
NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) — LEXEO Therapeutics (LEXEO), a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined sub-group of Alzheimer’s disease, today announced a strategic investment from Sarepta Therapeutics, Inc. (Sarepta) to support the advancement of LEXEO’s adeno-associated virus (AAV) gene therapy programs. […]
Study design and setting This was a population-based cohort study using health administrative databases in Ontario, the most populous province of Canada. Permanent residents of Ontario receive physician and hospital services through the publicly-funded Ontario Health Insurance Plan (OHIP). Study population We included permanent residents aged ≥ 20 years with incident non-gestational diabetes diagnosed between January 1, […]
The old adage that “laughter is the best medicine” may contain an element of truth when it comes to heart health. A study has demonstrated that having a chuckle causes the tissue inside the heart to expand – and increases oxygen flow around the body. Patients with coronary artery disease who engaged in a course […]
Ultra-processed food significantly raises the risk of high blood pressure, heart disease, heart attacks and strokes, according to two studies that one expert says should serve as a wake-up call for governments worldwide. Global consumption of heavily processed items such as cereals, protein bars, fizzy drinks, ready meals and fast food has soared in recent […]
More than half of the British diet is linked to heart attacks and strokes, experts warn. A review of ultra-processed food, high in salt and sugar and used in popular snacks, found they raise cardiovascular risks by 24%. It comes as the Mirror reveals healthy, fresh produce is almost impossible to find in poorer areas. […]
Julian Gillmore, MBBS, MD, PhDCredit: American Heart Association The 30-month results of the phase 3 ATTRibute-CM trial provide the latest insight into the effects of acoramidis in people with transthyretin amyloid cardiomyopathy (ATTR-CM) ahead of a potential regulatory submission for the agent. Presented during a hot line session at the European Society of Cardiology (ESC) […]
A new analysis of the DELIVER trial indicated hospitalization as a first presentation of worsening heart failure in patients with heart failure with mildly reduced or preserved ejection fraction was significantly associated with subsequent mortality. Presented at the European Society of Cardiology Congress 2023, results from the secondary analysis of the DELIVER trial showed oral […]